Back
United States Cellular Vs. West Pharmaceutical Services Industry Stock Comparison
Buy
64
USM
United States Cellular
Last Price:
57.54
Seasonality Move:
2.58%
Sell
50
WST
West Pharmaceutical Services
Last Price:
316.64
Seasonality Move:
6.17%
Buy
64
United States Cellular (USM)
is a Buy
Is United States Cellular a Buy, Sell or Hold?
- The current United States Cellular [USM] share price is $57.49. The Score for USM is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- USM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
West Pharmaceutical Services (WST)
is a Sell
Is West Pharmaceutical Services a Buy, Sell or Hold?
- The current West Pharmaceutical Services [WST] share price is $316.50. The Score for WST is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- WST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
USM Stock Price Chart
What is United States Cellular's stock price today?
-
The United States Cellular share price today is $57.49
The current trend is moderately bearish and USM is experiencing slight selling pressure.
WST Stock Price Chart
What is West Pharmaceutical Services's stock price today?
-
The West Pharmaceutical Services share price today is $316.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WST is experiencing buying pressure, which is a positive indicator for future bullish movement.
USM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.3 | Buy |
| Relative Strength Index (14 RSI): | 45.62 | Sell |
| Chaikin Money Flow: | -181284 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.46 - 61.08) | Sell |
| Bollinger Bands (100): | (52.7 - 58.2) | Buy |
WST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.93 | Buy |
| Relative Strength Index (14 RSI): | 57.75 | Buy |
| Chaikin Money Flow: | 532552 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (287.68 - 311.24) | Buy |
| Bollinger Bands (100): | (293.24 - 322.1) | Buy |
USM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61 | Sell |
| 20-day SMA: | 58.93 | Sell |
| 50-day SMA: | 56.99 | Buy |
| 200-day SMA: | 47.74 | Buy |
| 8-day EMA: | 60.42 | Sell |
| 20-day EMA: | 59.36 | Sell |
| 50-day EMA: | 57.28 | Buy |
| 200-day EMA: | 49.61 | Buy |
WST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 311.41 | Buy |
| 20-day SMA: | 298.93 | Buy |
| 50-day SMA: | 301.69 | Buy |
| 200-day SMA: | 337.46 | Sell |
| 8-day EMA: | 309.74 | Buy |
| 20-day EMA: | 304.01 | Buy |
| 50-day EMA: | 303.33 | Buy |
| 200-day EMA: | 325.28 | Sell |
United States Cellular Earnings Growth & USM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.18 per share.
West Pharmaceutical Services Earnings Growth & WST Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.46 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.38 per share, and an increase next year of $0.90 per share.
United States Cellular Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
West Pharmaceutical Services Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||